TV personality Oprah Winfrey has selected Dr. Amelie Ramirez of UT Health San Antonio as a "Cycle Breaker" for her groundbreaking work to build health equity in the Latino community. Cycle Breakers is a video series from the Smithsonian Channel that spotlights leaders who are solving health disparities in marginalized communities. Each Cycle Breaker is chosen by Oprah to augment her documentary, The Color of Care, which chronicles how people of color suffer from systemically substandard US healthcare and how COVID-19 exposed the tragic consequences of this inequity. Ramirez's episode, released Oct. 3, 2022, features her life's work to break the cycles of inequities that worsen health for Latinos. "Cycles are tough to break. Amelie Ramirez is the driving force behind an ...
Clinical trials can help researchers learn to better treat asthma – but they need diverse volunteers. Black and Latino children who have severe asthma, are prone to asthma attacks, and live in low-income urban neighborhoods are underrepresented in asthma treatment clinical trials, even though they are more likely than whites to face health inequities that can exacerbate asthma symptoms. Fortunately, a recent National Institutes of Health (NIH)-funded clinical trial with mostly Black and Latino children found that a monoclonal antibody – mepolizumab – can decrease asthma attacks by 27%. Antibodies are made naturally in the body to fight infection. A monoclonal antibody is made in the laboratory and administered to patients to treat a variety of diseases and infections, ...
Today we honor Latinas who are mitigating health inequities and disparities in the Latino community for National Latina Day on Aug. 20, 2022. Here are their stories of resilience, hard work, and success.
Dr. Amelie G. Ramirez
Meet Amelie G. Ramirez, DrPH, an internationally recognized researcher and director of Salud America! and its home base, the Institute for Health Promotion Research at UT Health San Antonio. She is also Chair of the Department of Population Health Sciences, and Associate Director of Cancer Outreach and Engagement at Mays Cancer Center at UT Health San Antonio. Amelie has spent more than 30 years reducing chronic disease and cancer health disparities affecting Latinos through human and organizational communication research. Q: What inspired you to choose ...
Clinical trials can have big benefits. They help researchers learn more to help slow, manage, and treat Alzheimer’s and cancer for ourselves and our abuelos, moms, dads, and others we love. So then why don't many Latinos join? To address this issue, you’re invited to join our Zoom webinar — Why Should I Think about Joining a Clinical Trial? — at 6 p.m. CT on Wednesday, Aug. 17, 2022. Webinar speakers Dr. Adolfo Diaz Duque of UT Health San Antonio and Dr. Bárbara Segarra-Vázquez of the University of Puerto Rico will help health care professionals and the Latino public understand clinical trial processes, explore trials as treatment options, and share testimonials of real Latinos who have benefited from trials. Panelists will also cover the barriers that prevent ...
Clinical trials are responsible for many of today’s life-saving procedures and treatments. But finding and enrolling in clinical trials can be difficult process, especially for Latinos who may experience language barriers or lack of information. In response to these challenges, the National Heart, Lung, and Blood Institute (NHLBI) recently updated their search engine to better help patients find and enroll in an NHBLI-sponsored clinical trial. Available in Spanish, interested participants can now browse for clinical trials by age group, condition, and location. The search engine also includes an overview of how clinical trials work, who can participate, and benefits, risks, and safety measures of trials. Diseases and conditions studied in NHBLI-sponsored clinical trials ...
Latinos are expected to comprise well over 25% of the U.S. population by 2050. But they face health disparities in eye health, diabetes, obesity, cancer, and more, endangering the future health of the nation. Dr. Amelie G. Ramirez, director of Salud America! at UT Health San Antonio, will explore the causes of these disparities in a virtual presentation, "A New Vision for Reaching Latinos for Systemic and Behavioral Change," at 2:45 p.m. ET, July 14, 2022, at the 11th Annual Focus on Eye Health National Summit led by Prevent Blindness. The overall event, which is free, is set for July 13-14, 2022. "Our efforts must address structural inequities — from a lack of healthcare access to unaffordable housing to experiences of discrimination to a lack of diversity among health care ...
Substance abuse in the US is a public health problem that affects many people, including Latinos. Yet, Latinos are less likely than their White peers to get treatment they need. There is a new investigational treatment for substance abuse —the use of Repetitive Transcranial Magnetic Stimulation (rTMS), a non-invasive procedure that uses magnetic pulses to temporarily stimulate areas of the brain. Fortunately, you can make a difference by representing Latinos in the Stimulus Research Study, a clinical trial at UT Health San Antonio and other sites that will help researchers learn if the use of rTMS can help people reduce or stop their cocaine or methamphetamine use. “The rTMS clinical trial and others like it hope to develop and apply new treatments that work for Latinos ...
Latinos represent less than 10% of volunteers in cancer clinical trials. The lack of Latinos in clinical trials makes it harder for researchers to find treatments tailored for this group — which makes up 18.5% of the U.S. population and a diversity of heritages. This is why Drs. Amelie G. Ramirez and Patricia Chalela of UT Health San Antonio identified barriers and strategies to boost Latino representation in clinical trials in a new commentary in JCO Oncology Practice. It will take more than simply raising awareness of clinical trials to everyone. "To achieve equitable participation of Latinos and other underrepresented groups in clinical research, we need comprehensive approaches that address social and contextual barriers to participation," said Ramirez, leader of the ...
The National Institute of Health (NIH) Office of Research on Women’s Health is seeking comments on how to improve treatment for the intersection of women’s health and COVID-19. COVID-19 has impacted all women, but Latinas have been consistently at high risk. Not only has the disease disproportionately hit this population, but it also has caused delays in screenings and care for other women’s health issues. Responses will be accepted through Friday May 6, 2022. Update 5/20/22: 10 women submitted comments. See a sampling of comments below.
Comments Submitted by Women via Salud America!
Here are a few comments submitted to the NIH Office of Research on Women’s Health: "I had Covid in December with pneumonia. I was in bed for two and a half weeks and thought I was ...
